Mechanisms of disease: Cell death in acute renal failure and emerging evidence for a protective role of erythropoietin.
Acute renal failure--characterized by a sudden loss of the ability of the kidneys to excrete nitrogenous waste, and to maintain electrolyte homeostasis and fluid balance--is a frequently encountered clinical problem, particularly in the intensive care unit. Unfortunately, advances in supportive interventions have done little to reduce the high mortality associated with this condition. Might erythropoietin (EPO) have utility as a therapeutic agent in acute renal failure? This hormone mediates anti-apoptotic effects in the bone marrow, facilitating maturation and differentiation of erythroid progenitors. New evidence indicates that EPO also exerts anti-apoptotic effects in the brain, heart and vasculature, which can limit the degree of organ damage. Here, we review the emerging biological role of EPO in the kidney and the pathophysiology of ischemia-reperfusion injury in an attempt to understand the therapeutic potential of EPO in acute renal failure.
Sharples
Edward J
EJ
Centre for Experimental Medicine, Nephrology and Critical Care, The William Harvey Research Institute, St Bartholomew's and The Royal London School of Medicine and Dentistry, Queen Mary-University of London, London EC1M 6BQ, UK. edsharps@doctors.org.uk
Thiemermann
Christoph
C
Yaqoob
Magdi M
MM
D058186:Acute Kidney Injury / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control*; D000818:Animals; D017209:Apoptosis; D016923:Cell Death; D004921:Erythropoietin / Q000502:physiology / Q000627:therapeutic use*; D006801:Humans
D004921:Erythropoietin